Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Telo Genomics Corp V.TELO

Alternate Symbol(s):  TDSGF

Healthcare Industrials Biotechnology Conglomerates
Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of... see more

Recent & Breaking News (TSXV:TELO)

American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting

Newsfile November 1, 2023

Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation

Newsfile October 26, 2023

Telo Genomics launches cancer diagnostic platform in the U.S.

Jocelyn Aspa October 17, 2023

Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM - An Important Commercial Milestone Achieved

Newsfile October 17, 2023

Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting

Newsfile October 12, 2023

Telo Genomics Achieves Noteworthy International Standards Organization ("ISO") Regulatory Accreditation

Newsfile September 6, 2023

Telo Genomics Reports Substantial Progress Toward Clinical Launch of TeloView-SMM

Newsfile August 29, 2023

Telo Genomics Announces Agreement for Strategic Advisory Services

Newsfile June 30, 2023

Telo Genomics Completes Oversubscribed Private Placement

Newsfile June 14, 2023

Telo Genomics Presents Positive Data in Newly Diagnosed Multiple Myeloma Drug Resistance Study at EHA 2023

Newsfile June 12, 2023

Telo Genomics Announces Private Placement Increased to $2,766,375 from Previously Announced Private Placement of $2,000,000

Newsfile June 6, 2023

Telo Genomics Presents Superior Results of Its Smoldering Multiple Myeloma Studies at ASCO 2023

Newsfile June 5, 2023

Telo Genomics raising capital for multiple myeloma solution

Trevor Abes  May 19, 2023

Telo Genomics Announces Private Placement of Units

Newsfile May 19, 2023

Telo Genomics' Multiple Myeloma Drug Resistance Study Results Have Been Selected for Presentation at the 2023 European Hematology Congress

Newsfile May 4, 2023

Telo Genomics Achieves a Major Milestone - Results of Smoldering Myeloma Study Accepted for Presentation at ASCO Annual Meeting

Newsfile April 13, 2023

Telo Genomics Advances to Final Stage of Achieving ISO Certification

Newsfile March 15, 2023

Telo Genomics Launches Multiple Myeloma Advisory Board at the American Society of Hematology Annual Meeting

Newsfile February 22, 2023

Telo Genomics (TSXV:TELO) appoints Kris Weinberg as CEO

Shoran Devi December 12, 2022

Telo Genomics Appoints Kris Weinberg as Chief Executive Officer

Newsfile December 12, 2022